Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin
暂无分享,去创建一个
M. Kanaoka | M. Taiji | H. Gomi | K. Hayashi | R. Teramoto | Y. Itakura | T. Kimura | M. Heishi | H. Ishikawa | J. Sakai | J. Ichihara
[1] J. Nishioka,et al. Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells. , 2005, International journal of molecular medicine.
[2] X. Leverve,et al. Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. , 2004, The Biochemical journal.
[3] W. Holland,et al. Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase. , 2004, Biochemical pharmacology.
[4] A. Fukamizu,et al. Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.
[5] D. White,et al. Functional silencing of hepatic microsomal glucose‐6‐phosphatase gene expression in vivo by adenovirus‐mediated delivery of short hairpin RNA , 2004, FEBS letters.
[6] T. Osborne,et al. PGC-1α Activates CYP7A1 and Bile Acid Biosynthesis* , 2003, Journal of Biological Chemistry.
[7] Giovanni Galli,et al. Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed Cycle* , 2003, Journal of Biological Chemistry.
[8] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[9] M. Omata,et al. A novel mitochondrial Ca2+-dependent solute carrier in the liver identified by mRNA differential display. , 2003, The Journal of biological chemistry.
[10] P. Khatri,et al. Global functional profiling of gene expression ? ? This work was funded in part by a Sun Microsystem , 2003 .
[11] Steven C. Lawlor,et al. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data , 2003, Genome Biology.
[12] Atul Butte,et al. The use and analysis of microarray data , 2002, Nature Reviews Drug Discovery.
[13] T. Saeki,et al. Enhanced secretion of glucagon-like peptide 1 by biguanide compounds. , 2002, Biochemical and biophysical research communications.
[14] M. Kakei,et al. Effect of metformin on adipose tissue resistin expression in db/db mice. , 2002, Biochemical and biophysical research communications.
[15] T. Takeya,et al. Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator* , 2002, The Journal of Biological Chemistry.
[16] Samy I McFarlane,et al. Metformin: An Update , 2002, Annals of Internal Medicine.
[17] Duccio Cavalieri,et al. Pathway Processor: a tool for integrating whole-genome expression results into metabolic networks. , 2002, Genome research.
[18] Olle Ljunqvist,et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. , 2002, Diabetes.
[19] G. Mithieux,et al. Polyunsaturated Fatty Acyl Coenzyme A Suppress the Glucose-6-phosphatase Promoter Activity by Modulating the DNA Binding of Hepatocyte Nuclear Factor 4α* , 2002, The Journal of Biological Chemistry.
[20] T. Golub,et al. DNA microarrays in clinical oncology. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Margaret S. Wu,et al. Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.
[22] J. Girard,et al. Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes. , 2001, Biochemical pharmacology.
[23] K. Petersen,et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. , 2000, Diabetes.
[24] M. Owen,et al. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.
[25] M. Rigoulet,et al. Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.
[26] Joshua M. Stuart,et al. MICROARRAY EXPERIMENTS : APPLICATION TO SPORULATION TIME SERIES , 1999 .
[27] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[28] S. Hilsenbeck,et al. Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. , 1999, Journal of the National Cancer Institute.
[29] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] Michael Ruogu Zhang,et al. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. , 1998, Molecular biology of the cell.
[31] Carolyn B Levy,et al. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase. , 1998, Diabetes.
[32] G. Reaven,et al. Results of a Placebo-Controlled Study of the Metabolic Effects of the Addition of Metformin to Sulfonylurea-Treated Patients: Evidence for a central role of adipose tissue , 1997, Diabetes Care.
[33] R. DeFronzo,et al. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.
[34] L. Tartaglia,et al. Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.
[35] R. DeFronzo,et al. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. , 1995, The New England journal of medicine.
[36] G Dailey,et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[37] R. Gougeon,et al. Effect of NIDDM on the Kinetics of Whole-Body Protein Metabolism , 1994, Diabetes.
[38] Lawrence A Leiter,et al. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. , 1992, Endocrinology.
[39] P. Khatri,et al. Global functional profiling of gene expression. , 2003, Genomics.
[40] T. Osborne,et al. PGC-1alpha activates CYP7A1 and bile acid biosynthesis. , 2003, The Journal of biological chemistry.
[41] A. Hoffman,et al. PRECLINICAL EVALUATION OF PHARMACOKINETIC PHARMACOKINETIC PHARMACODYNAMIC RATIONALE FOR ORAL CR METFORMIN FORMULATION , 2001 .
[42] D. Lockhart,et al. Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.